ArticleScientific reports2026
Diagnosis of Alzheimer's disease with high accuracy via Petri net modeling of signaling pathways.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alzheimer's disease is a complex disorder of the nervous system. Diagnosing this disease is a costly process in which numerous laboratory tests and examinations are conducted. Most computational methods for Alzheimer's disease prediction face low accuracy due to challenges such as a limited number of training samples, noisy/overlapping data, and variability in gene expression. This study presents a reliable computational approach for predicting Alzheimer's disease through a new method of analyzing gene expression profiles from either brain tissue or blood samples. The proposed Petri net-based approach demonstrates superior diagnostic accuracy compared to existing methods across multiple gene expression datasets derived from both blood and brain tissue. The proposed method runs a Petri net model of the signaling pathways involved in complex nervous system disorders. In addition, the Petri net model provides step-by-step tracking of gene activation until the final diagnosis state is reached. An accurate understanding of the functions of the key genes of the signaling pathways involved in brain cell death will play a significant role in the early diagnosis of this complex disease and hopefully will lead to the identification of suitable preventive treatments or drug targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.